Skip to content

Transurethral bipolar plasma enucleation in the treatment of non-muscle invasive bladder cancer

Transurethral bipolar plasma enucleation in the treatment of non-muscle invasive bladder cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072595
Enrollment
Unknown
Registered
2023-06-19
Start date
2018-04-29
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder tumor

Interventions

Group T:Transurethral resection of bladder tumor
Group E:Transurethral bipolar plasma enucleation

Sponsors

Dongtai People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
38 Years to 81 Years

Inclusion criteria

Inclusion criteria: (1) NMIBC was confirmed by bladder biopsy pathology, clinical ultrasound and CT; (2) No distant metastasis or ureteral openings were found in preoperative imaging examination; (3) No other systemic tumors; (4) All patients completed routine blood routine, coagulation routine, blood biochemistry, electrocardiogram and other routine examinations before surgery, without serious underlying diseases, and could tolerate surgical treatment.

Exclusion criteria

Exclusion criteria: (1) with distant metastasis to bone or lung; (2) complicated with dysfunction of heart, liver, kidney and other important organs and abnormal coagulation function; (3) patients with mental abnormality who cannot cooperate with treatment independently; (4) Incomplete clinical data; (5) other types of tumors.

Design outcomes

Primary

MeasureTime frame
Residual urine volume of bladder;Maximum urine flow rate;Serum endothelial growth factor;Surgery time;Intraoperative bleeding;

Secondary

MeasureTime frame
Urinary retention;Infection of the incision;Closed nerve reflex;Urinary stimulation;

Countries

China

Contacts

Public Contactzhouxunrong

Dongtai People's Hospital

zhouxunrong0104@163.com+86 85253910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026